Adverum Biotech
Mary Anne Pamplona has extensive work experience in the field of clinical data management. Mary Anne began their career at Allergan in 2007, where they held multiple roles including Principal Clinical Research Associate, Principal Clinical Data Manager, Manager of Clinical Data Management, Sr. Manager of Clinical Data Management, and Associate Director of Clinical Data Management. Mary Anne then joined AbbVie in 2020 as an Associate Director of Clinical Data Management, and later moved to Adverum Biotechnologies, Inc. in 2022 to take on the role of Director of Clinical Data Management.
Mary Anne Pamplona has a Bachelor of Arts degree in Biology/Chemistry from Franklin Pierce University.
This person is not in any offices
Adverum Biotech
10 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.